Polymicrobial infection in patients with cancer: an underappreciated and underreported entity.
about
Critical care of patients with cancerNoisy neighbourhoods: quorum sensing in fungal-polymicrobial infectionsPneumonia in the neutropenic cancer patientInfections in Cancer Patients with Solid Tumors: A Review.Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).How we treat febrile neutropenia in patients receiving cancer chemotherapyPolymicrobial bloodstream infections in the neonatal intensive care unit are associated with increased mortality: a case-control study.Current Microbiology of Surgical Site Infections in Patients with Cancer: A Retrospective ReviewDevelopment and antimicrobial susceptibility studies of in vitro monomicrobial and polymicrobial biofilm models with Aspergillus fumigatus and Pseudomonas aeruginosa.Performance of a standardized bronchoalveolar lavage protocol in a comprehensive cancer center: a prospective 2-year study.Bloodstream infections in neutropenic cancer patients: A practical update.Factors affecting patient outcome in primary cutaneous aspergillosis.Matched case-control analysis of polymicrobial bloodstream infection in a neonatal intensive care unit.Concurrent lung infections in patients with hematological malignancies and invasive pulmonary aspergillosis: how firm is the Aspergillus diagnosis?Outcome of severe infections in afebrile neutropenic cancer patients.Current microbiology of percutaneous endoscopic gastrostomy tube (PEG tube) insertion site infections in patients with cancer.Characteristics of, and risk factors for, infections in patients with cancer treated with dasatinib and a brief review of other complications.Colorectal cancer emergencies.The current spectrum of infection in cancer patients with chemotherapy related neutropenia.Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent.Pediatric patients with intravascular devices: polymicrobial bloodstream infections and risk factors.Future Research Priorities in Fungal Resistance.In vitro activity of dalbavancin and five comparator agents against common and uncommon Gram-positive organisms isolated from cancer patients.Polymicrobial pulmonary infection in patients with hematological malignancies: prevalence, co-pathogens, course and outcome.Polymicrobial bacterial or fungal infections: incidence, spectrum of infection, risk factors, and clinical outcomes from a large hematopoietic stem cell transplant center.Deciphering the aetiology of a mixed fungal infection by broad-range PCR with sequencing and fluorescence in situ hybridisation.Candida albicans and Enterococcus faecalis in the gut: synergy in commensalism?Hematological: Low all-cause mortality and low occurrence of antimicrobial resistance in hematological patients with bacteremia receiving no antibacterial prophylaxis: a single-center study.Infections in non-myeloablative hematopoietic stem cell transplantation patients with lymphoid malignancies: spectrum of infections, predictors of outcome and proposed guidelines for fungal infection prevention.Polymicrobial pulmonary infections in cancer patients with underlying solid tumors.A fresh look at polymicrobial bloodstream infection in cancer patients.Post-Obstructive Pneumonia in Patients with Cancer: A Review.Clinical outcomes and prognostic factors of cancer patients with pyogenic liver abscess.Postobstructive Pneumonia in Cancer Patients.Silver-coated gold nanorods as a promising antimicrobial agent in the treatment of cancer-related infections
P2860
Q26746976-5392BF56-7339-4584-A591-841EDA6D8908Q26799027-911EBFC6-517C-4D23-945F-C86B802A61A8Q26827758-5A30E97E-B01D-48A5-B2EB-E436BD75217EQ30238576-1CEEA08D-4791-4E7D-B092-7D28CCC33C33Q30608976-51F75893-6550-45F1-B43D-CFD470883492Q33846201-2A68E173-B9A3-43D2-84D9-B044BC17EF74Q34485426-C74838DA-7351-4248-AA69-FE30E941A83DQ34726054-3E19E493-0A1B-4AB0-BAE7-FE8336C8753DQ35109394-A45C8944-F020-46D5-ABB4-0368F2A6562DQ36277727-40521EAA-D695-40AB-AE18-2F88C1D45425Q36913345-060DCE0F-AD9E-4DDE-AFD1-20C33074ACBAQ37077844-75333AE4-0159-4188-900D-5626AA4ADFE4Q37276068-83DB8E19-3CC8-4375-A9DD-7D862955F81AQ37373785-867B958B-2287-46C8-81A6-8A43EC022504Q37432031-CAB52E2C-6720-471E-9212-8F3DAFA7CB34Q37873400-DF6B7283-B2CB-4D4C-B26E-407043C50881Q37977471-3661631C-5E1F-43B7-9099-1D8D80EADDA6Q38078309-1394090B-4062-47EF-B796-91E30656E709Q38131442-AB44FE7E-EECC-4D36-9A64-AFDAF8E621B0Q39281555-59C427A8-E827-4DD9-8DA7-74D7F83B9C38Q39800090-10999798-6A97-4F51-A37D-E3BF25C4FEB9Q40045680-B026CDDD-20FC-4D4B-9AFB-4A776F216C9CQ40252885-258116F8-5FA1-435B-B130-D0D443B401ACQ40824442-80D4754A-7AF4-439F-B0D3-2BC554997FA5Q41484869-5EDCF4F0-9C86-4928-833C-9B86271FF09EQ42267894-EB2BCC82-7808-443F-AEA0-BC9893CFBB9DQ42869350-E1547498-01E9-476D-AA88-6755C4A70DF8Q43984868-AA9A20FE-C9BB-45EE-80AA-7B048AC3B1F8Q44951826-CA4BCB79-DA7A-4D93-97CA-FA78098CC630Q48035009-3D1DF094-628F-452C-BD60-0A98C3F67B56Q48136538-55A2564D-D905-4AEA-BBCF-F2EAFB0F7EC5Q50214737-FAAB5391-68E5-4B0A-B5E7-E0C8185E900FQ51016620-9C845373-6E7A-4741-850A-05E483B610A5Q54572426-E77960A7-251D-4587-9F67-37887FD1A352Q58544219-98C8D3F1-875A-415A-8E38-24ECADA17A98
P2860
Polymicrobial infection in patients with cancer: an underappreciated and underreported entity.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Polymicrobial infection in pat ...... ated and underreported entity.
@en
type
label
Polymicrobial infection in pat ...... ated and underreported entity.
@en
prefLabel
Polymicrobial infection in pat ...... ated and underreported entity.
@en
P2093
P356
P1476
Polymicrobial infection in pat ...... ated and underreported entity.
@en
P2093
Amar Safdar
Gerald P Bodey
Kenneth V I Rolston
P304
P356
10.1086/518873
P407
P577
2007-06-04T00:00:00Z